Subjects | Outcome | Number of eventsa | Q2 versus Q1 | Q3 versus Q1 | Q4 versus Q1 | Pfor linear trend |
---|---|---|---|---|---|---|
HR (95% CI) | HR (95% CI) | HR (95% CI) | ||||
All subjects | All-cause mortality | 8.39 | 1.04 (0.76 to 1.42) | 1.22 (0.90 to 1.65) | 1.52 (1.13 to 2.06) | 0.002** |
Cancer mortality | 3.88 | 1.11 (0.70 to 1.74) | 1.56 (1.01 to 2.41) | 1.78 (1.13 to 2.77) | 0.004** | |
CVD mortality | 2.34 | 1.18 (0.64 to 2.19) | 1.01 (0.55 to 1.85) | 1.42 (0.79 to 2.57) | 0.266 | |
Mortality from causes other than cancer and CVD | 2.16 | 0.90 (0.49 to 1.66) | 1.07 (0.59 to1.93) | 1.47 (0.82 to 2.63) | 0.126 | |
Men | All-cause mortality | 11.14 | 0.99 (0.67 to 1.47) | 0.96 (0.66 to 1.40) | 1.52 (1.07 to 2.16) | 0.024* |
Cancer mortality | 4.92 | 1.71 (0.95 to 3.07) | 1.38 (0.76 to 2.50) | 2.37 (1.36 to 4.14) | 0.006** | |
CVD mortality | 3.13 | 0.66 (0.30 to 1.45) | 0.69 (0.34 to 1.39) | 1.18 (0.62 to 2.25) | 0.539 | |
Mortality from causes other than cancer and CVD | 3.09 | 0.71 (0.33 to 1.53) | 0.91 (0.46 to 1.78) | 1.28 (0.67 to 2.45) | 0.428 | |
Women | All-cause mortality | 6.30 | 1.29 (0.76 to 2.20) | 1.37 (0.79 to 2.38) | 1.61 (0.94 to 2.75) | 0.081 |
Cancer mortality | 3.13 | 1.43 (0.72 to 2.83) | 1.17 (0.55 to 2.48) | 1.57 (0.76 to 3.23) | 0.352 | |
CVD mortality | 1.74 | 0.86 (0.27 to 2.97) | 1.38 (0.43 to 4.44) | 1.47 (0.47 to 4.62) | 0.245 | |
Mortality from causes other than cancer and CVD | 1.46 | 1.50 (0.47 to 4.77) | 1.93 (0.59 to 6.28) | 1.90 (0.58 to 6.16) | 0.281 |